Aster spathulifolius
Aster spathulifolius · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Aster spathulifolius is a significant medicinal plant species recognized for its diverse therapeutic potential. Researchers frequently investigate its biological activities through the use of specialized preparations, most notably the Aster spathulifolius extract (ASE). Studies often focus on the methanol extract to isolate and analyze its potent bioactive compounds. These chemical constituents contribute to the plant's reputation in traditional and modern pharmacological applications. Understanding these specific extracts is essential for unlocking the full medicinal value of this species.
- Synonyms
- Aster Chusanensis · Aster Feddei · 10 more
- Common names
- Not available
- Family
- Asteraceae
- Distribution
- Southern America
- Plant Parts
- Not available
Classification
Common Names
Aster spathulifolius is a fascinating plant known by a diverse array of regional names across different cultures. In Japan, it is affectionately referred to as both Haeguk and daruma-giku, or alternatively written in kanji as 海菊 and ダルマギク. Moving into a Russian context, the species is identified by the descriptive name Астра лопатчатолистная. These varied common names reflect the plant's wide geographical reach and its cultural significance in various parts of Asia. Understanding these linguistic connections helps botanists and enthusiasts identify the species regardless of their native tongue.
Sources: Catalogue of Life (COL)
Synonyms
Aster spathulifolius is a complex botanical species characterized by a variety of recognized taxonomic synonyms. Within its diverse lineage, the plant is also known by the names Aster chusanensis and Aster feddei. Furthermore, scientific literature identifies it under the synonym Aster oharae. The species also encompasses specific color variations, such as the forms classified as Aster spathulifolius f. albiflorus and Aster spathulifolius f. albus. Understanding these overlapping names is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Aster spathulifolius belongs to the vast kingdom Plantae, representing the diverse world of living vegetation. Within this kingdom, the species is classified under the class Equisetopsida. It further falls into the order Asterales, showcasing its evolutionary lineage. As a member of the genus Aster, it shares close ties with many other well-known flowering plants. Finally, this plant is a distinguished representative of the Asteraceae family.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asterales |
| Family | Asteraceae |
| Genus | Aster |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Aster spathulifolius is a resilient species primarily found within the Asia-Temperate region. Its natural range extends across Eastern Asia, encompassing much of Japan and the Korean peninsula. Beyond these coastal areas, the plant also thrives in the Russian Far East, specifically within the Primorye region. This broad distribution highlights the plant's ability to adapt to various temperate climates throughout the continent. Consequently, understanding these specific geographical patterns is essential for studying its ecological niche.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Aster spathulifolius is a herbaceous plant characterized by its distinct growth form. This species can reach a maximum height of approximately 1.5 meters.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Aster spathulifolius contains labdane diterpenes that demonstrate significant cytotoxic effects against various cancer cell lines. Specifically, the plant's compounds work to treat HCT15 tumor cells through nonspecific cytotoxicity. Research also indicates that these extracts are effective in treating SK-MEL-2 tumor cells. Furthermore, the medicinal properties of the plant extend to the treatment of SK-OV-3 tumor cells. Finally, Aster spathulifolius has been shown to treat XF498 tumor cells as well as human A549 tumor cells.
Preparations
Aster spathulifolius is prepared as Aster spathulifolius extract (ASE) to investigate its potential anti-melanogenic properties in UVB-exposed models. This ASE is utilized to study the inhibition of melanin synthesis and the regulation of specific signaling pathways. Additionally, Aster spathulifolius is prepared as a methanol extract from its aerial parts for chemical analysis. This methanol extract facilitates the isolation of various labdane diterpenes, including three newly identified compounds. These specific preparations allow researchers to explore both the pharmacological effects and the cytotoxic potential of the plant.